Transapical Implantation of the Medtronic Engager Transcatheter Aortic Valve Implantation System - The Engager European Pivotal Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 125 participants.

Also called NCT01348438

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 125 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01348438
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Germany, Israel, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01348438. Allocation not applicable; no masking; primary purpose treatment. Start 2011-09-12 (actual); primary completion 2013-02-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Transapical Implantation of the Medtronic Engager Transcatheter Aortic Valve Implantation System - The Engager European Pivotal Trial
Condition
Aortic Valve Stenosis
Intervention (Device)
Medtronic Engager Transcatheter Aortic Valve Implantation System
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure (class: industry)

Record details

Record id
cardio:ct-nct01348438
Content hash
5db8d526bc38ce7efaab139e53b7b3b6ff749c8e8aab0b883b6369f22635752f